Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Serono Geref To Be Discontinued In November, Novartis Priscoline In Q2

Apr 01 2002

• By The Pink Sheet

Related Content

Serono Geref Phase IV dose-optimization study should focus on effect of multiple injections, FDA says.

Oct 06 1997

Drug Discontinuation Requirements Would Be Expanded Under DeWine Bill

Apr 01 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window